AGP Picks
View all

Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on May 15, 2026

Blue Star Mothers of America Honors Military Caregivers Nationwide
PitPat Launches Sports Club 42 Pedal to Win Online Cycling Challenge Expanding the Future of Interactive Digital Fitness
Verathon Expands Urology Portfolio with CFlex™,  Its First Single-Use Flexible Cystoscope
SeniorCRE® Launches the First Unified Operating System for the Post–Point-Solution Era of Senior Living and Care
Chinese Neurosurgical Journal Study Shows Heat-Based Therapy Alters Epilepsy Brain Networks
Role of Environmental Enrichment in Poststroke Functional Recovery
Gulf Coast Industrial Growth Increases Workforce Housing Demand
UPDATE – Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
Dibamed Dental Clinic Introduces NightLase®: A Laser-Based Snoring Treatment for UAE Residents
Range Impact Reports 1Q 2026 Financial Results
NUTIFOOD FDI FORMULA GRANTED USPTO PATENT, AFFIRMING ITS GLOBAL NUTRITIONAL SCIENCE CAPABILITIES
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
 Yenssen Biotech Expands Global Reach, Seeks Distribution Partners for CE- and FDA-Cleared Advanced Wound Care Products
Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
Aktionärinnen und Aktionäre der BioNTech SE stimmen auf der ordentlichen Hauptversammlung 2026 allen Tagesordnungspunkten zu
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026
Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification
4DMT Announces New Employment Inducement Grants
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting

Share this page:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.